logo

Xencor Inc (XNCR)



Trade XNCR now with
  Date
  Headline
7/18/2018 6:00:59 AM Kodiak Sciences Appoints Bassil Dahiyat, Robert Profusek And Richard Levy To Board
5/8/2018 7:54:13 AM Wedbush Is Cutting Xencor Inc (XNCR) FY18 Rev. Estimate To 7.5 M From 20.0 M
5/8/2018 7:54:02 AM Wedbush Is Cutting Xencor Inc (XNCR) Q4 18 Rev. Estimate To 2.5 M From 5.0 M
5/8/2018 7:53:57 AM Wedbush Is Lowering Xencor Inc (XNCR) Q3 18 Rev. Estimate To 2.5 M From 5.0 M
5/8/2018 7:53:48 AM Wedbush Is Cutting Xencor Inc (XNCR) Q2 18 Rev. Estimate To 2.5 M From 5.0 M
5/8/2018 7:53:21 AM Wedbush Is Increasing Xencor Inc (XNCR) FY19 Estimate To -2.10 From -2.43
5/8/2018 7:53:06 AM Wedbush Is Raising Xencor Inc (XNCR) Q4 19 Estimate To -0.53 From -0.62
5/8/2018 7:52:56 AM Wedbush Is Raising Xencor Inc (XNCR) Q3 19 Estimate To -0.53 From -0.61
5/8/2018 7:52:43 AM Wedbush Is Increasing Xencor Inc (XNCR) Q2 19 Estimate To -0.52 From -0.60
5/8/2018 7:52:36 AM Wedbush Is Raising Xencor Inc (XNCR) Q1 19 Estimate To -0.52 From -0.60
5/8/2018 7:52:18 AM Wedbush Is Cutting Xencor Inc (XNCR) FY18 Estimate To -2.18 From -2.10
5/8/2018 7:52:01 AM Wedbush Is Raising Xencor Inc (XNCR) Q4 18 Estimate To -0.55 From -0.63
5/8/2018 7:51:48 AM Wedbush Is Raising Xencor Inc (XNCR) Q3 18 Estimate To -0.52 From -0.57
5/8/2018 7:51:36 AM Wedbush Is Lowering Xencor Inc (XNCR) Q2 18 Estimate To -0.50 From -0.47
5/7/2018 4:05:42 PM Xencor Q1 Loss/share $0.62 Vs. Loss $0.33 Year Ago
2/26/2018 8:15:01 AM Xencor Signs 4 Commercial License Deals With Selexis SA To Advance Pipeline Of XmAb Bispecific Antibody Drug Candidates
2/22/2018 8:05:36 AM Xencor Doses First Patient In Phase 1 Study Of XmAb 18087 Bispecific Tumor Targeting Antibody
12/18/2017 12:11:29 PM Wedbush Is Raising Xencor Inc (XNCR) FY17 Estimate To -0.85 From -1.06